Commerce Bank Eli Lilly & CO Transaction History

Commerce Bank

$15.9 Billion
Q4 2024

A detailed history of Commerce Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Commerce Bank holds 164,214 shares of LLY stock, worth $139 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

164,214

Previous 129,977 26.34%

Holding current value

$139 Million

Previous $115 Million 10.09%

% of portfolio

0.79%

Previous 0.71%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$727.2 - $932.06 $24.9 Million - $31.9 Million	34,237 Added 26.34%	164,214 $127 Million
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $79,530 - $98,882	-103 Reduced 0.08%	129,977 $115 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $816,928 - $1.02 Million	-1,127 Reduced 0.86%	130,080 $118 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $528,834 - $707,506	-893 Reduced 0.68%	131,207 $102 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $162,808 - $191,930	-310 Reduced 0.23%	132,100 $77 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.51 Million - $2.08 Million	-3,476 Reduced 2.56%	132,410 $71.1 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $5.57 Million - $7.45 Million	15,875 Added 13.23%	135,886 $63.7 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $930,958 - $1.09 Million	2,997 Added 2.56%	120,011 $41.2 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $10.3 Million - $12 Million	32,123 Added 37.84%	117,014 $42.8 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $44,768 - $51,018	-151 Reduced 0.18%	84,891 $27.4 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3.07 Million - $3.6 Million	-11,008 Reduced 11.46%	85,042 $27.6 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $705,243 - $876,438	-3,005 Reduced 3.03%	96,050 $27.5 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $5,846 - $7,255	-26 Reduced 0.03%	99,055 $27.4 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $1.29 Million - $1.58 Million	5,809 Added 6.23%	99,081 $22.9 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $520,706 - $673,529	-2,884 Reduced 3.0%	93,272 $21.4 Million
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $407,842 - $527,971	-2,482 Reduced 2.52%	96,156 $18 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $194,907 - $257,909	-1,494 Reduced 1.49%	98,638 $16.7 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $620,411 - $717,618	-4,243 Reduced 4.07%	100,132 $14.8 Million
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $270,930 - $326,061	1,986 Added 1.94%	104,375 $17.1 Million
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $310,601 - $384,436	2,609 Added 2.61%	102,389 $14.2 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $7,270 - $9,005	-68 Reduced 0.07%	99,780 $13.1 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $70,694 - $76,897	662 Added 0.67%	99,848 $11.2 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $155,770 - $181,823	1,406 Added 1.44%	99,186 $11 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $1.93 Million - $2.28 Million	-17,374 Reduced 15.09%	97,780 $12.7 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $481,103 - $538,981	4,543 Added 4.11%	115,154 $13.3 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $385,854 - $482,251	-4,494 Reduced 3.9%	110,611 $11.9 Million
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $83,951 - $96,349	1,109 Added 0.97%	115,105 $9.82 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $798,276 - $942,313	10,757 Added 10.42%	113,996 $8.82 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $1.64 Million - $1.76 Million	20,052 Added 24.1%	103,239 $8.72 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $234,215 - $259,956	3,039 Added 3.79%	83,187 $6.85 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $6.18 Million - $6.86 Million	80,148	80,148 $6.86 Million

Others Institutions Holding LLY

# of Institutions

4,229

Shares Held

755M

Call Options Held

9.22M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $802B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account